Inventor · disambiguated record
Fubao Wang
Also filed as: WANG FUBAO
5 granted patents·7 pending applications·12 citations·filing 2008–2015
73Inventor score
Files withACUMEN PHARMACEUTICALS INC3MERCK SHARP & DOHME2AN ZHIQIANG1ANDERSON ANNALIESA S1ASTE-AMEZAGA JOSE MIGUEL1
Top patents by PatentIndex Score
12 records- 0181US7994293B2Antibodies specific for Dkk-1MERCK SHARP & DOHME·Filed 2008·Granted Aug 9, 2011·7 cites·13 claims
- 0277US9309309B2Anti-ADDL monoclonal antibody and uses thereofMERCK SHARP & DOHME·Filed 2014·Granted Apr 12, 2016·3 cites·10 claims
- 0365US9320793B2Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2012·Granted Apr 26, 2016·1 cites·1 claims
- 0464US9310383B2Antibodies, kit and method for detecting amyloid beta oligomersACUMEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 12, 2016·1 cites·8 claims
- 0557US2011286916A1Generation and characterization of anti-notch antibodies for therapeutic and diagnostic useASTE-AMEZAGA JOSE MIGUEL·Filed 2009·Application pending·0 cites
- 0647US2015320860A1Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0743US2013115227A1Anti-addl monoclonal antibody and uses thereofGASPAR RENEE C·Filed 2011·Application pending·0 cites
- 0841US9176151B2Antibodies, kit and method for detecting amyloid beta oligomersGOURE WILLIAM F·Filed 2012·Granted Nov 3, 2015·0 cites·13 claims
- 0940US2012201835A1Antibodies specific for dkk-1AN ZHIQIANG·Filed 2011·Application pending·0 cites
- 1039US2010166772A1ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657nANDERSON ANNALIESA S·Filed 2008·Application pending·0 cites
- 1138US2009104210A1Peptide compounds for treating obesity and insulin resistanceTOTA MICHAEL R·Filed 2008·Application pending·0 cites
- 1229US2012219558A1Antagonists of pcsk9NI YAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fubao Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →